Skip to content

Study comparing vaginal energy equipment

Laser and Radiofrequency treatment in women with Genitourinary Menopause Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5vw3vpg
Enrollment
Unknown
Registered
2022-12-26
Start date
2023-02-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Climacteric

Interventions

48 post-menopausal women with symptoms of genitourinary syndrome of menopause will be interviewed and after evaluation of the inclusion and exclusion criteria they will be randomized into 4 different
E07.632.490

Sponsors

Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Lead Sponsor
Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Post-menopausal women; genitourinary menopausal syndrome symptoms; vaginal dryness complaint

Exclusion criteria

Exclusion criteria: Vaginal estrogen use in the last 6 months; current or past 6 months use of systemic hormone replacement therapy; presence of stage III or IV pelvic organ prolapses; use of pacemaker; decompensated heart disease; cognitive deficit; peripheral or central neurological disorders; presence of any type of cancer or cervical dysplasia; hx of active urinary or vaginal infection; decompensated metabolic diseases

Design outcomes

Primary

MeasureTime frame
It is expected to find that the groups using microablative and non-ablative laser and microablative and non-ablative Radiofrequency will present significant improvement of more than 80% of symptoms through visual analogue scale of symptoms of the genitourinary syndrome of menopause and of the histological parameters evaluated through the greater amount of neocollagenesis.

Secondary

MeasureTime frame
It is expected to find that women treated with non-ablative erbium-doped yttrium aluminium garnet laser, microablative dioxidy carbon laser, non-ablative radiofrequency and fractional microablative radiofrequency will show similar improvement, with no statistical difference, in symptoms of genitourinary menopausal syndrome, stress urinary incontinence, overactive bladder and sexual function assessed using the genitourinary menopausal syndrome symptoms visual analogue scale, Incontinence Questionnaire-urinary Incontinence Short Form (ICIQ-SF), International Consultation on Incontinence Overactive Bladder Questionnaire (ICIQ-OAB) and Female Sexual Function Index (FSFI), respectively.;We believe that the vaginal mucosa of women treated with different types of energy will show an increase in the thickness of the epithelium and an increase in the concentration of collagen fibers through histological evaluation, but this increase will be higher in those treated with microablative dioxidy carbon laser. ;It is expected to find that all treatments will present few adverse events, with no difference between them and that most women will feel satisfied with the treatment.

Countries

Brazil

Contacts

Public ContactHelena Slongo

Hospital da Mulher Prof. Dr. José Aristodemo Pinotti - CAISM

slongohelena@gmail.com+55(41)999966880

Outcome results

None listed

Source: REBEC (via WHO ICTRP) · Data processed: Feb 3, 2026